Study directory

Mental health studies with practical context.

Compare studies and check their requirements with the research team.

Back to overview
More filters: keywords, city, remote
1743studies shown
Showing 889-900 of 1,743
Drug study icon
Not recruitingEUCTR 2016-001637-27

A randomised pragmatic trial comparing the clinical and cost effectiveness of lithium and quetiapine augmentation in treatment resistant depression.

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In United Kingdom
DepressionDrugA study involving a medication or substance.
Countries
United Kingdom
Sponsor
South London and Maudsley NHS Foundation Trust [...] 1. South London and Maudsley NHS Foundation Trust 2. King's College London
Condition
Depression
Drug study icon
Not recruitingISRCTN48548553

Effectiveness of two antidepressants (escitalopram, a selective serotonin re-uptake inhibitor, SSRI) and (nortriptyline, a tricyclic antidepressant, TCA) compared to placebo in depression

This study is not recruiting in the United Kingdom. It is testing two antidepressants (escitalopram, a selective serotonin re-uptake inhibitor, SSRI) and (nortriptyline, a tricyclic antidepressant, TCA) compared to placebo for depression.

In United Kingdom
Depression, Eating disordersOtherOver 18 Years
Countries
United Kingdom
Sponsor
University College London
Condition
Depression, Eating disorders
Drug study icon
Not recruitingEUCTR 2008-000908-91

A randomised, 6-week, multicentre, open-label, rater-blinded parallelgroup study comparing Quetiapine extended release monotherapy and augmentation with Lithium augmentation in patients with Treatm...

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In United Kingdom
DepressionDrug
Countries
United Kingdom, Belgium, Austria, ...
Sponsor
AstraZeneca AB
Condition
Depression
Drug study icon
Not recruitingEUCTR 2008-001580-11

A Randomized, Double-Blind, Parallel-Group, Placebo-Controlled, Fixed-Dose Study Comparing the Efficacy and Safety of 3 Doses of Lu AA21004 in Acute Treatment of Adults With Major Depressive Disorder

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In United Kingdom
DepressionDrug
Countries
France, United Kingdom, Germany, ...
Sponsor
Takeda Global Research & Development Centre (Europe) Ltd.
Condition
Depression
Drug study icon
Not recruitingEUCTR 2008-001766-90

A Randomized, Double-Blind, Parallel-Group, Placebo-Controlled, Fixed-Dose Study Comparing the Efficacy and Safety of a Single Dose of Lu AA21004 in Acute Treatment of Adults With Generalized Anxie...

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In United Kingdom
AnxietyDrug
Countries
United Kingdom, Estonia, Germany, ...
Sponsor
Takeda Global Research & Development Centre (Europe) Ltd.
Condition
Anxiety
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.